share_log

Amedisys Analyst Ratings

Amedisys Analyst Ratings

Amedisys 分析師評級
Benzinga ·  2023/08/01 03:42
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/31/2023 11.24% TD Cowen $84 → $101 Maintains Market Perform
07/27/2023 11.24% Credit Suisse → $101 Reiterates Neutral → Neutral
07/06/2023 11.24% Jefferies $98 → $101 Downgrades Buy → Hold
06/28/2023 — Benchmark Downgrades Buy → Hold
06/27/2023 — Benchmark Downgrades Buy → Hold
06/27/2023 11.24% Truist Securities $97 → $101 Maintains Hold
06/07/2023 6.84% Truist Securities → $97 Downgrades Buy → Hold
06/06/2023 10.14% Cantor Fitzgerald $91 → $100 Maintains Neutral
06/06/2023 26.66% Benchmark → $115 Reiterates Buy → Buy
06/06/2023 10.14% Credit Suisse $115 → $100 Downgrades Outperform → Neutral
05/08/2023 -7.48% TD Cowen $95 → $84 Maintains Market Perform
05/05/2023 -3.07% Barclays $93 → $88 Maintains Equal-Weight
05/04/2023 6.84% Truist Securities $115 → $97 Maintains Buy
05/04/2023 13.45% Stephens & Co. → $103 Reiterates → Equal-Weight
04/21/2023 -4.18% Cantor Fitzgerald → $87 Initiates Coverage On → Neutral
04/13/2023 26.66% Truist Securities $130 → $115 Maintains Buy
03/14/2023 26.66% Benchmark → $115 Reiterates → Buy
03/14/2023 13.45% Stephens & Co. → $103 Reiterates → Equal-Weight
03/13/2023 2.43% Barclays → $93 Initiates Coverage On → Equal-Weight
02/27/2023 26.66% Credit Suisse → $115 Reiterates → Outperform
02/21/2023 22.26% RBC Capital $114 → $111 Maintains Outperform
02/16/2023 4.64% Stephens & Co. → $95 Reiterates → Equal-Weight
02/16/2023 26.66% Benchmark $120 → $115 Maintains Buy
02/13/2023 32.17% Benchmark → $120 Reiterates → Buy
01/25/2023 32.17% Benchmark $135 → $120 Maintains Buy
01/23/2023 26.66% Credit Suisse $140 → $115 Maintains Outperform
01/19/2023 37.68% Oppenheimer $145 → $125 Maintains Outperform
01/05/2023 -6.38% SVB Leerink $96 → $85 Maintains Market Perform
11/11/2022 16.75% Stephens & Co. $122 → $106 Maintains Equal-Weight
11/01/2022 5.74% SVB Leerink $116 → $96 Maintains Market Perform
11/01/2022 34.37% Stephens & Co. $105 → $122 Maintains Equal-Weight
10/31/2022 53.1% RBC Capital $165 → $139 Maintains Outperform
10/28/2022 38.78% Barclays $154 → $126 Maintains Overweight
10/28/2022 15.65% Stephens & Co. $120 → $105 Maintains Equal-Weight
10/28/2022 43.19% Truist Securities $140 → $130 Maintains Buy
10/28/2022 59.71% Oppenheimer $175 → $145 Maintains Outperform
10/27/2022 — Raymond James Downgrades Outperform → Market Perform
10/24/2022 81.74% Deutsche Bank $175 → $165 Maintains Buy
10/05/2022 54.2% Truist Securities $150 → $140 Maintains Buy
10/03/2022 48.69% Benchmark $165 → $135 Maintains Buy
08/02/2022 4.64% UBS $145 → $95 Downgrades Neutral → Sell
08/01/2022 54.2% Raymond James $180 → $140 Maintains Outperform
07/29/2022 69.62% Barclays $181 → $154 Maintains Overweight
07/28/2022 81.74% Benchmark $175 → $165 Maintains Buy
07/14/2022 65.21% Truist Securities $175 → $150 Maintains Buy
06/29/2022 40.98% Stifel → $128 Initiates Coverage On → Hold
06/21/2022 12.35% B of A Securities $145 → $102 Downgrades Neutral → Underperform
06/21/2022 92.75% Deutsche Bank $210 → $175 Maintains Buy
06/21/2022 92.75% Truist Securities $200 → $175 Maintains Buy
06/21/2022 37.68% Stephens & Co. $155 → $125 Maintains Equal-Weight
06/21/2022 17.85% SVB Leerink $117 → $107 Maintains Market Perform
05/27/2022 28.87% SVB Leerink $131 → $117 Maintains Market Perform
04/29/2022 100.46% Credit Suisse $181 → $182 Maintains Outperform
04/29/2022 98.26% Raymond James $200 → $180 Maintains Outperform
04/29/2022 44.29% SVB Leerink $162 → $131 Maintains Market Perform
03/01/2022 85.04% UBS $152 → $168 Upgrades Sell → Neutral
02/25/2022 114.78% Credit Suisse $200 → $195 Maintains Outperform
02/25/2022 120.29% Oppenheimer $225 → $200 Maintains Outperform
02/25/2022 109.27% BMO Capital → $190 Upgrades Market Perform → Outperform
02/24/2022 92.75% Benchmark $200 → $175 Maintains Buy
02/18/2022 61.91% SVB Leerink $145 → $147 Maintains Market Perform
12/21/2021 134.6% Barclays $236 → $213 Maintains Overweight
11/08/2021 147.82% Raymond James $250 → $225 Maintains Outperform
11/04/2021 125.79% Credit Suisse $192 → $205 Maintains Outperform
11/04/2021 103.76% Stephens & Co. $178 → $185 Maintains Equal-Weight
11/04/2021 143.42% RBC Capital $244 → $221 Maintains Outperform
11/04/2021 99.36% SVB Leerink $170 → $181 Maintains Market Perform
11/03/2021 147.82% Oppenheimer $265 → $225 Maintains Outperform
10/13/2021 109.27% Truist Securities $255 → $190 Maintains Buy
09/27/2021 87.24% SVB Leerink → $170 Initiates Coverage On → Market Perform
09/24/2021 65.21% UBS → $150 Initiates Coverage On → Sell
09/10/2021 114.78% Cowen & Co. → $195 Initiates Coverage On → Market Perform
08/11/2021 175.36% Credit Suisse $330 → $250 Maintains Outperform
08/10/2021 158.84% Benchmark $325 → $235 Maintains Buy
08/10/2021 175.36% Raymond James $325 → $250 Maintains Outperform
08/06/2021 191.88% Oppenheimer $325 → $265 Maintains Outperform
08/06/2021 161.04% Stephens & Co. $310 → $237 Maintains Equal-Weight
08/05/2021 142.31% B of A Securities → $220 Downgrades Buy → Neutral
02/23/2021 257.96% Benchmark $275 → $325 Maintains Buy
02/08/2021 274.49% Deutsche Bank $275 → $340 Maintains Buy
10/30/2020 208.4% Credit Suisse $246 → $280 Maintains Outperform
09/21/2020 186.37% Oppenheimer $250 → $260 Maintains Outperform
09/02/2020 197.39% BMO Capital $250 → $270 Maintains Market Perform
07/30/2020 197.39% SunTrust Robinson Humphrey $260 → $270 Maintains Buy
07/30/2020 180.86% Raymond James $210 → $255 Maintains Outperform
07/30/2020 186.37% Deutsche Bank $220 → $260 Maintains Buy
07/30/2020 175.36% Benchmark $210 → $250 Maintains Buy
07/30/2020 186.37% RBC Capital $218 → $260 Maintains Outperform
07/29/2020 175.36% Jefferies $225 → $250 Maintains Buy
07/10/2020 186.37% SunTrust Robinson Humphrey $240 → $260 Maintains Buy
06/18/2020 131.3% Benchmark → $210 Upgrades Hold → Buy
05/21/2020 164.34% SunTrust Robinson Humphrey $225 → $240 Maintains Buy
05/11/2020 109.27% UBS $208 → $190 Maintains Neutral
05/11/2020 131.3% Raymond James $225 → $210 Maintains Outperform
03/09/2020 125.79% Benchmark → $205 Upgrades Hold → Buy
02/21/2020 129.1% UBS $154 → $208 Maintains Neutral
02/21/2020 120.29% Stephens & Co. $180 → $200 Maintains Equal-Weight
02/20/2020 147.82% SunTrust Robinson Humphrey $185 → $225 Maintains Buy
02/20/2020 147.82% Raymond James $200 → $225 Maintains Outperform
01/17/2020 126.89% Credit Suisse → $206 Initiates Coverage On → Outperform
01/03/2020 120.29% Raymond James $144 → $200 Maintains Outperform
12/18/2019 103.76% SunTrust Robinson Humphrey $175 → $185 Maintains Buy
12/06/2019 87.24% BMO Capital → $170 Initiates Coverage On → Market Perform
11/26/2019 96.05% B of A Securities $170 → $178 Maintains Buy
11/20/2019 87.24% B of A Securities $163 → $170 Reiterates → Buy
11/07/2019 69.62% UBS $144 → $154 Maintains Neutral
11/01/2019 — Baird Upgrades Neutral → Outperform
10/22/2019 59.71% Stephens & Co. → $145 Reinstates → Equal-Weight
09/17/2019 70.72% Deutsche Bank → $155 Initiates Coverage On → Buy
08/05/2019 37.68% Barclays $120 → $125 Maintains Equal-Weight
07/15/2019 58.61% Raymond James $140 → $144 Maintains Outperform
05/02/2019 54.2% Raymond James → $140 Upgrades Market Perform → Outperform
03/21/2019 32.17% Barclays $115 → $120 Maintains Equal-Weight
02/05/2019 — Benchmark Downgrades Buy → Hold
12/14/2018 43.19% Barclays → $130 Initiates Coverage On → Equal-Weight
11/16/2018 38.78% UBS → $126 Initiates Coverage On → Neutral
10/30/2018 — Benchmark Upgrades Hold → Buy
10/26/2018 14.55% Craig-Hallum $116 → $104 Downgrades Buy → Hold
10/11/2018 32.17% Baird $105 → $120 Maintains Neutral
10/11/2018 37.68% Cantor Fitzgerald $117 → $125 Maintains Neutral
09/18/2018 53.1% B of A Securities $116 → $139 Maintains Buy
09/13/2018 28.87% Cantor Fitzgerald → $117 Initiates Coverage On → Neutral
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
07/31/2023 11.24% TD Cowen $84→$101 維護 市場表現
07/27/2023 11.24% 瑞士信貸 →$101 重申 中性→中性
07/06/2023 11.24% 傑富瑞 $98→$101 評級下調 購買→Hold
2023年6月28日 - 基準 評級下調 購買→Hold
2023年6月27日 - 基準 評級下調 購買→Hold
2023年6月27日 11.24% Truist證券 $97→$101 維護 保持
06/07/2023 6.84% Truist證券 →$97 評級下調 購買→Hold
06/06/2023 10.14% 康託·菲茨傑拉德 $91→$100 維護 中性
06/06/2023 26.66% 基準 →$115 重申 購買→購買
06/06/2023 10.14% 瑞士信貸 $115→$100 評級下調 跑贏→中性
05/08/2023 -7.48% TD Cowen $95→$84 維護 市場表現
05/05/2023 -3.07% 巴克萊 $93→$88 維護 等重
05/04/2023 6.84% Truist證券 $115→$97 維護 買
05/04/2023 13.45% 斯蒂芬斯公司 →$103 重申 →等重
04/21/2023 -4.18% 康託·菲茨傑拉德 →$87 開始承保 →中性
04/13/2023 26.66% Truist證券 $130→$115 維護 買
03/14/2023 26.66% 基準 →$115 重申 →購買
03/14/2023 13.45% 斯蒂芬斯公司 →$103 重申 →等重
03/13/2023 2.43% 巴克萊 →$93 開始承保 →等重
02/27/2023 26.66% 瑞士信貸 →$115 重申 →跑贏大盤
02/21/2023 22.26% 加拿大皇家銀行資本 $114→$111 維護 跑贏大盤
02/16/2023 4.64% 斯蒂芬斯公司 →$95 重申 →等重
02/16/2023 26.66% 基準 $120→$115 維護 買
02/13/2023 32.17% 基準 →$120 重申 →購買
2023年1月25日 32.17% 基準 $135→$120 維護 買
2023年1月23日 26.66% 瑞士信貸 $140→$115 維護 跑贏大盤
2023年1月19日 37.68% 奧本海默 $145→$125 維護 跑贏大盤
01/05/2023 -6.38% SVB Leerink $96→$85 維護 市場表現
2022年11月11日 16.75% 斯蒂芬斯公司 $122→$106 維護 等重
11/01/2022 5.74% SVB Leerink $116→$96 維護 市場表現
11/01/2022 34.37% 斯蒂芬斯公司 $105→$122 維護 等重
2022年10月31日 53.1% 加拿大皇家銀行資本 $165→$139 維護 跑贏大盤
10/28/2022 38.78% 巴克萊 $154→$126 維護 超重
10/28/2022 15.65% 斯蒂芬斯公司 $120→$105 維護 等重
10/28/2022 43.19% Truist證券 $140→$130 維護 買
10/28/2022 59.71% 奧本海默 $175→$145 維護 跑贏大盤
10/27/2022 - 雷蒙德·詹姆斯 評級下調 跑贏→市場表現
10/24/2022 81.74% 德意志銀行 $175→$165 維護 買
10/05/2022 54.2% Truist證券 $150→$140 維護 買
10/03/2022 48.69% 基準 $165→$135 維護 買
08/02/2022 4.64% 瑞銀集團 $145→$95 評級下調 中性→銷售
08/01/2022 54.2% 雷蒙德·詹姆斯 $180→$140 維護 跑贏大盤
07/29/2022 69.62% 巴克萊 $181→$154 維護 超重
07/28/2022 81.74% 基準 $175→$165 維護 買
07/14/2022 65.21% Truist證券 $175→$150 維護 買
2022/06/29 40.98% Stifel →$128 開始承保 →保留
2022年06月21日 12.35% B of A證券 $145→$102 評級下調 中性→表現不佳
2022年06月21日 92.75% 德意志銀行 $210→$175 維護 買
2022年06月21日 92.75% Truist證券 $200→$175 維護 買
2022年06月21日 37.68% 斯蒂芬斯公司 $155→$125 維護 等重
2022年06月21日 17.85% SVB Leerink $117→$107 維護 市場表現
2022年05月27日 28.87% SVB Leerink $131→$117 維護 市場表現
04/29/2022 100.46% 瑞士信貸 $181→$182 維護 跑贏大盤
04/29/2022 98.26% 雷蒙德·詹姆斯 $200→$180 維護 跑贏大盤
04/29/2022 44.29% SVB Leerink $162→$131 維護 市場表現
03/01/2022 85.04% 瑞銀集團 $152→$168 升級 賣出→中性
02/25/2022 114.78% 瑞士信貸 $200→$195 維護 跑贏大盤
02/25/2022 120.29% 奧本海默 $225→$200 維護 跑贏大盤
02/25/2022 109.27% 蒙特利爾銀行資本 →$190 升級 市場表現優於→
02/24/2022 92.75% 基準 $200→$175 維護 買
02/18/2022 61.91% SVB Leerink $145→$147 維護 市場表現
2021/12/21 134.6% 巴克萊 $236→$213 維護 超重
11/08/2021 147.82% 雷蒙德·詹姆斯 $250→$225 維護 跑贏大盤
11/04/2021 125.79% 瑞士信貸 $192→$205 維護 跑贏大盤
11/04/2021 103.76% 斯蒂芬斯公司 $178→$185 維護 等重
11/04/2021 143.42% 加拿大皇家銀行資本 $244→$221 維護 跑贏大盤
11/04/2021 99.36% SVB Leerink $170→$181 維護 市場表現
11/03/2021 147.82% 奧本海默 $265→$225 維護 跑贏大盤
10/13/2021 109.27% Truist證券 $255→$190 維護 買
09/27/2021 87.24% SVB Leerink →$170 開始承保 →市場表現
09/24/2021 65.21% 瑞銀集團 →$150 開始承保 →銷售
09/10/2021 114.78% 考恩公司 →$195 開始承保 →市場表現
2021/08/11 175.36% 瑞士信貸 $330→$250 維護 跑贏大盤
2021/08/10 158.84% 基準 $325→$235 維護 買
2021/08/10 175.36% 雷蒙德·詹姆斯 $325→$250 維護 跑贏大盤
08/06/2021 191.88% 奧本海默 $325→$265 維護 跑贏大盤
08/06/2021 161.04% 斯蒂芬斯公司 $310→$237 維護 等重
08/05/2021 142.31% B of A證券 →$220 評級下調 購買→中性
02/23/2021 257.96% 基準 $275→$325 維護 買
02/08/2021 274.49% 德意志銀行 $275→$340 維護 買
10/30/2020 208.4% 瑞士信貸 $246→$280 維護 跑贏大盤
2020/09/21 186.37% 奧本海默 $250→$260 維護 跑贏大盤
09/02/2020 197.39% 蒙特利爾銀行資本 $250→$270 維護 市場表現
07/30/2020 197.39% SunTrust Robinson Humphrey $260→$270 維護 買
07/30/2020 180.86% 雷蒙德·詹姆斯 $210→$255 維護 跑贏大盤
07/30/2020 186.37% 德意志銀行 $220→$260 維護 買
07/30/2020 175.36% 基準 $210→$250 維護 買
07/30/2020 186.37% 加拿大皇家銀行資本 $218→$260 維護 跑贏大盤
07/29/2020 175.36% 傑富瑞 $225→$250 維護 買
07/10/2020 186.37% SunTrust Robinson Humphrey $240→$260 維護 買
06/18/2020 131.3% 基準 →$210 升級 持有→購買
2020/05/21 164.34% SunTrust Robinson Humphrey $225→$240 維護 買
05/11/2020 109.27% 瑞銀集團 $208→$190 維護 中性
05/11/2020 131.3% 雷蒙德·詹姆斯 $225→$210 維護 跑贏大盤
03/09/2020 125.79% 基準 →$205 升級 持有→購買
02/21/2020 129.1% 瑞銀集團 $154→$208 維護 中性
02/21/2020 120.29% 斯蒂芬斯公司 $180→$200 維護 等重
02/20/2020 147.82% SunTrust Robinson Humphrey $185→$225 維護 買
02/20/2020 147.82% 雷蒙德·詹姆斯 $200→$225 維護 跑贏大盤
2020/01/17 126.89% 瑞士信貸 →$206 開始承保 →跑贏大盤
1/03/2020 120.29% 雷蒙德·詹姆斯 $144→$200 維護 跑贏大盤
2019年12月18日 103.76% SunTrust Robinson Humphrey $175→$185 維護 買
2019年6月12日 87.24% 蒙特利爾銀行資本 →$170 開始承保 →市場表現
2019年11月26日 96.05% B of A證券 $170→$178 維護 買
2019年11月20日 87.24% B of A證券 $163→$170 重申 →購買
2019/07/11 69.62% 瑞銀集團 $144→$154 維護 中性
2019/11/01 - 貝爾德 升級 中性→表現優異
2019年10月22日 59.71% 斯蒂芬斯公司 →$145 恢復 →等重
2019/09/17 70.72% 德意志銀行 →$155 開始承保 →購買
2019年08月05日 37.68% 巴克萊 $120→$125 維護 等重
2019年07月15日 58.61% 雷蒙德·詹姆斯 $140→$144 維護 跑贏大盤
2019年05月02日 54.2% 雷蒙德·詹姆斯 →$140 升級 市場表現優於→
2019年03月21日 32.17% 巴克萊 $115→$120 維護 等重
2019年05月02日 - 基準 評級下調 購買→Hold
2018年12月14日 43.19% 巴克萊 →$130 開始承保 →等重
2018年11月16日 38.78% 瑞銀集團 →$126 開始承保 →中性
2018年10月30日 - 基準 升級 持有→購買
2018年10月26日 14.55% 克雷格-哈勒姆 $116→$104 評級下調 購買→Hold
2018年10月11日 32.17% 貝爾德 $105→$120 維護 中性
2018年10月11日 37.68% 康託·菲茨傑拉德 $117→$125 維護 中性
2018年09月18日 53.1% B of A證券 $116→$139 維護 買
2018年09月13日 28.87% 康託·菲茨傑拉德 →$117 開始承保 →中性

What is the target price for Amedisys (AMED)?

Amedisys(Amed)的目標價是多少？

The latest price target for Amedisys (NASDAQ: AMED) was reported by TD Cowen on July 31, 2023. The analyst firm set a price target for $101.00 expecting AMED to rise to within 12 months (a possible 11.24% upside). 42 analyst firms have reported ratings in the last year.

TD Cowen於2023年7月31日報道了Amedisys(納斯達克代碼：AMED)的最新目標價。這家分析公司將目標價定為101.00美元，預計Amed將在12個月內上漲至11.24%(可能上漲11.24%)。去年有42家分析公司公佈了評級。

What is the most recent analyst rating for Amedisys (AMED)?

Amedisys(Amed)的最新分析師評級是多少？

The latest analyst rating for Amedisys (NASDAQ: AMED) was provided by TD Cowen, and Amedisys maintained their market perform rating.

TD Cowen提供了對Amedisys(納斯達克代碼：AMED)的最新分析師評級，Amedisys維持其市場表現評級。

When is the next analyst rating going to be posted or updated for Amedisys (AMED)?

Amedisys(Amed)的下一次分析師評級將於何時發佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amedisys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amedisys was filed on July 31, 2023 so you should expect the next rating to be made available sometime around July 31, 2024.

分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Amedisys的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Amedisys的上一次評級是在2023年7月31日提交的，所以你應該預計下一次評級將在2024年7月31日左右的某個時候公佈。

Is the Analyst Rating Amedisys (AMED) correct?

分析師對Amedisys(Amed)的評級正確嗎？

While ratings are subjective and will change, the latest Amedisys (AMED) rating was a maintained with a price target of $84.00 to $101.00. The current price Amedisys (AMED) is trading at is $90.79, which is within the analyst's predicted range.

雖然評級是主觀的，並將發生變化，但最新的Amedisys(AMED)評級維持不變，目標價在84美元至101.00美元之間。Amedisys(Amed)目前的交易價格為90.79美元，在分析師的預測區間內。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論